Novartis Targets Teva Over Myfortic Patents
By Erin Marie Daly · April 20, 2011, 4:57 PM EDT
Novartis AG accused Israeli generics maker Teva Pharmaceutical Industries Ltd. in Delaware on Wednesday of infringing a group of its patents related to immunosuppressive agent Myfortic....
To view the full article, register now.